Celyad S.A.
Stock Exchange Euronext Brussels
EPS
EUR3.38
Market Cap
EUR135.19 M
Shares Outstanding
11.94 M
Public Float
9.24 M
Celyad S.A.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
11.52 M
Public Float
-
Celyad S.A. ADR
Stock Exchange NASDAQ Stock Market
EPS
$3.99
Market Cap
$154.53 M
Shares Outstanding
11.94 M
Public Float
-

Profile

Address
Axis Business Park
Mont-Saint-Guibert WA 1435
Belgium
Employees -
Website http://www.celyad.com
Updated 07/08/2019
Celyad SA is a clinical-stage biopharmaceutical company, which engages in the identification and development of specialized cell-based therapies. Its products include cardiopoiesis platform, immuno-oncology, and medical devices. The company was founded by Michel Lussier and William Wijns on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.

Financials

View All
Created with Highcharts 5.0.14Celyad S.A.Net Income. Fiscal year is January-December. All values EUR Thousands.14 48914 48916 45316 45329 11429 11423 60623 60656 39556 39537 42737 427201320142015201620172018010k20k30k40k50k60k
Created with Highcharts 5.0.14Celyad S.A.Sales/Revenue. Fiscal year is January-December. All values EUR Thousands.00146146338 5238 5233 5403 5403 1153 11520132014201520162017201802k4k6k8k10k

Michel E. Lussier
Chairman
Margo R. Roberts
Director